With new funding from the Falk Medical Trust, Professor Seungpyo Hong and Allan Brasier, executive director of the UW Institute for Clinical and Translational Research, are paving the way for a novel treatment for idiopathic pulmonary fibrosis.
fibrosis
Grant Fuels Development of Inhalable Nanomedicine for Lung Diseases
With funding from the Discovery to Product program, Professor Seungpyo Hong and his collaborators are accelerating their research on idiopathic pulmonary fibrosis.
New Potential Drug to Treat Fibrosis
Researchers in the School of Pharmacy’s Kwon Lab have been awarded a patent for a promising new therapy with implications for many conditions, such as kidney disease, heart failure, and even COVID-19.